Halozyme Therapeutics
AECFeaturedFinanceIndustry NewsLife ScienceSan Diego
San Diego Lab R&D Leasing Holds Steady as Capital Flows Offset Elevated Vacancy
Q4 activity reaches 283,000 square feet while large fundraises reinforce confidence in core biotech submarkets After a period defined more by consolidation than...
CommercialFinanceIndustry NewsLife ScienceNews ReleasesSan Diego
Halozyme Therapeutics Leases 72,534 SQFT at Del Mar Corporate Centre in San Diego
SAN DIEGO, Calif., – June 15, 2022 – Cushman & Wakefield announced that Halozyme Therapeutics, a biopharmaceutical company bringing disruptive solutions to significantly...
